Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1992 1
1993 9
1994 3
1995 1
1996 4
1997 2
1998 2
1999 1
2000 3
2001 5
2002 10
2003 5
2004 4
2005 7
2006 12
2007 6
2008 9
2009 6
2010 3
2011 3
2012 13
2013 5
2014 7
2015 9
2016 10
2017 12
2018 17
2019 23
2020 19
2021 10
Text availability
Article attribute
Article type
Publication date

Search Results

189 results
Results by year
Filters applied: . Clear all
Page 1
Gabapentin in pregnancy and the risk of adverse neonatal and maternal outcomes: A population-based cohort study nested in the US Medicaid Analytic eXtract dataset.
Patorno E, Hernandez-Diaz S, Huybrechts KF, Desai RJ, Cohen JM, Mogun H, Bateman BT. Patorno E, et al. PLoS Med. 2020 Sep 1;17(9):e1003322. doi: 10.1371/journal.pmed.1003322. eCollection 2020 Sep. PLoS Med. 2020. PMID: 32870921 Free PMC article.
BACKGROUND: Despite the widespread use, only sparse information is available on the safety of gabapentin during pregnancy. We sought to evaluate the association between gabapentin exposure during pregnancy and risk of adverse neonatal and maternal outc …
BACKGROUND: Despite the widespread use, only sparse information is available on the safety of gabapentin during pregnancy. We …
Medication Use and Pain Management in Pregnancy: A Critical Review.
Black E, Khor KE, Kennedy D, Chutatape A, Sharma S, Vancaillie T, Demirkol A. Black E, et al. Pain Pract. 2019 Nov;19(8):875-899. doi: 10.1111/papr.12814. Epub 2019 Aug 13. Pain Pract. 2019. PMID: 31242344 Review.
BACKGROUND: Pain during pregnancy is common, and its management is complex. Certain analgesics may increase the risk for adverse fetal and pregnancy outcomes, while poorly managed pain can result in adverse maternal outcomes such as depression and hypertension. ...F …
BACKGROUND: Pain during pregnancy is common, and its management is complex. Certain analgesics may increase the risk for adverse feta …
Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis.
Veroniki AA, Rios P, Cogo E, Straus SE, Finkelstein Y, Kealey R, Reynen E, Soobiah C, Thavorn K, Hutton B, Hemmelgarn BR, Yazdi F, D'Souza J, MacDonald H, Tricco AC. Veroniki AA, et al. BMJ Open. 2017 Jul 20;7(7):e017248. doi: 10.1136/bmjopen-2017-017248. BMJ Open. 2017. PMID: 28729328 Free PMC article. Review.
Epileptic women who did not receive AEDs during pregnancy or breast feeding served as the control group. PRIMARY AND SECONDARY OUTCOME MEASURES: Cognitive developmental delay and autism/dyspraxia were primary outcomes. ...Oxcarbazepine and lamotrigine were associated with …
Epileptic women who did not receive AEDs during pregnancy or breast feeding served as the control group. PRIMARY AND SECONDARY OUTCOM …
Menopause.
Potter B, Schrager S, Dalby J, Torell E, Hampton A. Potter B, et al. Prim Care. 2018 Dec;45(4):625-641. doi: 10.1016/j.pop.2018.08.001. Epub 2018 Oct 5. Prim Care. 2018. PMID: 30401346 Review.
Therapeutic Drug Monitoring of Antiepileptic Drugs in Women with Epilepsy Before, During, and After Pregnancy.
Arfman IJ, Wammes-van der Heijden EA, Ter Horst PGJ, Lambrechts DA, Wegner I, Touw DJ. Arfman IJ, et al. Clin Pharmacokinet. 2020 Apr;59(4):427-445. doi: 10.1007/s40262-019-00845-2. Clin Pharmacokinet. 2020. PMID: 31912315 Review.
Postpartum elimination rates of lamotrigine, levetiracetam, and licarbazepine resumed to pre-pregnancy values within the first few weeks after pregnancy. We advise monitoring of antiepileptic drug trough concentrations twice before pregnancy. ...Monitoring of …
Postpartum elimination rates of lamotrigine, levetiracetam, and licarbazepine resumed to pre-pregnancy values within the first few we …
Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial.
Horne AW, Vincent K, Hewitt CA, Middleton LJ, Koscielniak M, Szubert W, Doust AM, Daniels JP; GaPP2 collaborative. Horne AW, et al. Lancet. 2020 Sep 26;396(10255):909-917. doi: 10.1016/S0140-6736(20)31693-7. Lancet. 2020. PMID: 32979978 Free PMC article. Clinical Trial.
BACKGROUND: Chronic pelvic pain affects 2-24% of women worldwide and evidence for medical treatments is scarce. Gabapentin is effective in treating some chronic pain conditions. We aimed to measure the efficacy and safety of gabapentin in women with chronic pelvic p …
BACKGROUND: Chronic pelvic pain affects 2-24% of women worldwide and evidence for medical treatments is scarce. Gabapentin is effecti …
Drugs for anxiety disorders.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2019 Aug 12;61(1578):121-126. Med Lett Drugs Ther. 2019. PMID: 31386647 Review. No abstract available.
Drugs for chronic insomnia.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2018 Dec 17;60(1562):201-205. Med Lett Drugs Ther. 2018. PMID: 30625122 Review. No abstract available.
Potential maternal symptomatic benefit of gabapentin and review of its safety in pregnancy.
Guttuso T Jr, Shaman M, Thornburg LL. Guttuso T Jr, et al. Eur J Obstet Gynecol Reprod Biol. 2014 Oct;181:280-3. doi: 10.1016/j.ejogrb.2014.08.013. Epub 2014 Aug 17. Eur J Obstet Gynecol Reprod Biol. 2014. PMID: 25195202 Review.
We reviewed published pregnancy registries and cohorts for pregnancy outcomes associated with maternal gabapentin use. ...Controlled, clinical trials are needed to assess gabapentin's effectiveness for HG....
We reviewed published pregnancy registries and cohorts for pregnancy outcomes associated with maternal gabapentin use. …
189 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page